A&G Pharmaceutical

A&G Pharmaceutical is a theranostics company focused on developing monoclonal antibodies targeting cancer-specific markers as the foundation for novel therapeutic and diagnostic products. The company is currently advancing a near-term opportunity to develop and commercialize a series of diagnostic test kits that will enhance the early detection, diagnosis, and treatment of breast cancer based on GP88, a patented and proprietary growth factor discovered by A&G researchers. Meanwhile, A&G's therapeutic division is developing anti-GP88 monoclonal antibody therapies for cancer. A&G’s custom antibody services fund drug development efforts by accelerating the generation of novel functional antibody therapies for leading pharmaceutical and biotechnology companies as well as federal laboratories.